The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
Open Access
- 1 October 2019
- journal article
- review article
- Published by Elsevier BV in Annals Of Oncology
- Vol. 30 (10), 1572-1579
- https://doi.org/10.1093/annonc/mdz206
Abstract
Immune-checkpoint inhibitors (ICI) now represent the standard of care for several cancer types. In pre-clinical models, absence of an intact gut microbiome negatively impacted ICI efficacy and these findings permitted to unravel the importance of the commensal microbiota in immuno-oncology. Recently, multiple clinical studies including more than 1800 patients in aggregate demonstrated the negative predictive impact of treatments with broad-spectrum antibiotics (ATB) on cancer patients receiving ICI. Altogether, these results have led to the hypothesis that ATB-induced dysbiosis might influence the clinical response through the modulation of the gut microbiome. Controversy still remains, as ATB treatment might simply constitute a surrogate marker of unfit or immunodeficient patients. In this review, we summarize recent publications addressing the impact of the gut microbiome on ICI efficacy, discuss currently available data on the effect of ATB administered in different time-frames respect to ICI initiation, and finally, evoke the therapeutic implications of these findings.Keywords
Funding Information
- Montreal Cancer Institute
This publication has 62 references indexed in Scilit:
- Frequent Antibiotic Use and Second Breast Cancer EventsCancer Epidemiology, Biomarkers & Prevention, 2013
- Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapyPharmacological Research, 2012
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4Cancer Cell, 2012
- The human microbiome: at the interface of health and diseaseNature Reviews Genetics, 2012
- Reshaping the gut microbiome with bacterial transplantation and antibiotic intakeGenome Research, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Association between antibiotic use and risk of prostate cancerInternational Journal of Cancer, 2010
- Non-invasive markers of gut wall integrity in health and diseaseWorld Journal of Gastroenterology, 2010
- Antibiotic Use and the Risk of Lung CancerCancer Epidemiology, Biomarkers & Prevention, 2008
- Antibiotics and Risk of Breast Cancer: Up to 9 Years of Follow-up of 2.1 Million WomenCancer Epidemiology, Biomarkers & Prevention, 2006